Reports for TEVA CANADA LIMITED

Company Name
TEVA CANADA LIMITED

Shortage reports

Actual shortage:

259 (8%)

Anticipated shortage:

1 (0%)

Avoided shortage:

10 (0%)

Resolved:

3057 (92%)

3327

Discontinuation Reports

To be discontinued:

2 (0%)

Discontinued:

411 (94%)

Reversed:

23 (5%)

436

485 (13%)

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TRISENOX 1MG SOLUTION Resolved 2017-07-14 2018-07-30 15753
TRISENOX 10MG SOLUTION Actual shortage 2020-05-14 2022-06-03 115216
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-08-22 2019-10-10 92198
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2024-12-10 2025-04-24 245304
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-01-27 98185
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-03-12 2020-08-27 108601
VINBLASTINE SULPHATE INJECTION 1MG SOLUTION Resolved 2020-11-06 2021-01-07 128028
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-07-03 2026-03-12 261785
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-01-30 2025-04-24 249198
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2024-12-20 2026-03-12 246267
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-02-21 2020-04-09 106925
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2025-08-14 2026-03-12 265143
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2020-08-06 2020-11-07 121865
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144448
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144451
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Avoided shortage 2021-08-23 2021-08-23 144454
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144494
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2021-08-24 2022-01-07 144497
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-28 2020-06-25 99955
VINCRISTINE SULFATE INJECTION 1MG SOLUTION Resolved 2019-11-07 2020-02-21 98179

Showing 3301 to 3320 of 3327

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-LISINOPRIL/HCTZ (TYPE P) 25MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81368
TEVA-LORAZEPAM 1MG TABLET Discontinued 2025-05-28 2025-05-28 258513
TEVA-LOSARTAN/HCTZ 50.0MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133902
TEVA-LOSARTAN/HCTZ 100MG 25MG TABLET Discontinued 2021-02-12 2021-02-12 133899
TEVA-LOSARTAN/HCTZ 100MG 12.5MG TABLET Discontinued 2021-02-12 2021-02-12 133896
TEVA-MEDROXYPROGESTERONE 2.5MG TABLET Discontinued 2025-04-29 2025-04-29 256113
TEVA-MEDROXYPROGESTERONE 5MG TABLET Discontinued 2025-04-29 2025-04-29 256116
TEVA-MEDROXYPROGESTERONE 10MG TABLET Discontinued 2025-04-29 2025-04-29 256119
TEVA-METFORMIN 850MG TABLET Reversed 2025-05-28 2025-06-04 258449
TEVA-METFORMIN 500MG TABLET Reversed 2025-05-28 2025-06-04 258452
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258568
TEVA-METOPROLOL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258537
TEVA-METOPROLOL 50MG TABLET Discontinued 2020-07-10 2020-07-10 119976
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Reversed 2025-05-28 2025-06-04 258532
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-05-28 2025-05-28 258535
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MODAFINIL 100MG TABLET Discontinued 2025-05-28 2025-05-28 258732
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055